Released Nov 12, 2026, after the close
10-Q filed Nov 13, 2026, 44 days after period end · 0001493152-26-051690
What the release said
On November 12, 2026, Dyadic International, Inc. (“Dyadic”) issued a press release announcing its results for the quarter ended September 30, 2026.
Dyadic reported total revenue of $449,101 for the three months ended September 30, 2026, a decrease of 61.4% from $1,164,617 a year earlier.¶2
Net loss for the three months ended September 30, 2026 was $1,357,041, or $(0.04) per share, compared to $1,976,012, or $(0.06) per share, a year earlier.¶3
Cash, cash equivalents, restricted cash, and investment-grade securities were $6,046,083 as of September 30, 2026, compared to $8,587,289 as of December 31, 2025.¶4
Dyadic recorded its first direct commercial product sales in the third quarter, and expects to receive a $225,000 milestone payment from Inzymes in the fourth quarter of 2026.¶5¶6
- Total revenue
- $449,101 Three months ended September 30, 2026, compared to $1,164,617 for the three months ended September 30, 2025¶2
- Net loss
- $1,357,041 Three months ended September 30, 2026, compared to $1,976,012 for the same period a year ago¶3
- Net loss per share
- $(0.04) Three months ended September 30, 2026, compared to $(0.06) for the same period a year ago¶3
- Cash position
- $6,046,083 As of September 30, 2026, compared to $8,587,289 as of December 31, 2025¶4
Same quarter
| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $449.10K | $1.16M | $1.96M | $397.06K |
| Net Income | -$1.36M | -$1.98M | -$203.46K | -$1.61M |
| EPS Diluted | -$0.04 | -$0.06 | -$0.01 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dyadic International Inc · CIK 1213809 · Engraved from SEC EDGAR